Keywords

• Eptifibatide
• Eptifibatide Acetate
• 188627-80-7

Quick Details

• ProName: Eptifibatide
• CasNo: 188627-80-7
• Molecular Formula: C35h49n11o9s2
• Appearance: white powder
• Application: Eptifibatide
• DeliveryTime: 5 days
• PackAge: Vial or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 100 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 10 Milligram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

One of the remarkable features of our Eptifibatide is its rapid onset of action. It quickly reaches therapeutic levels in the bloodstream, exerting its anti - platelet effects almost immediately. This rapid response is crucial in emergency situations where time is of the essence. Moreover, its action is reversible. Once the treatment is discontinued, platelet function gradually returns to normal, minimizing the risk of excessive bleeding. This unique characteristic allows for precise control of the anti - platelet therapy, enhancing patient safety.

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details

Eptifibatide CAS No.:  188627-80-7

Peptide Sequence: 
Mpa-Har-Gly-Asp-Trp-Pro-Cys-NH₂(Disulfide bridge: Mpa1-Cys6)

Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events.

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.